Solana Co

SOL.X · Crypto · US

21 employees · heliusmedical.com

About

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2014-06-27. The firm focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain's ability to heal itself. The Company’s offered product is portable neuromodulation stimulator (PoNS) device. PoNS is an authorized class II, non-implantable, medical device in Canada intended for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy. The PoNS device is developed to deliver to the tongue a non-invasive neurostimulation, in a form that induces neuromodulation.

Annual results

Reported figures, USD

YearRevenueNet incomeNet marginFree cash flow
20256.0M-40.0M-666.7%—
2024—-11.0M—-11.0M
2023—-8.0M—-10.4M
2022—-14.0M—-14.3M
2021—-18.0M—-13.4M

SOL.X in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Solana Co are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Solana Co (SOL.X) — company profile and financials · MarketPulse